NCT06201741

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Huashan Hospital · Academic / Other
• Sex: Male
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the safety, biodistribution, radiation dosimetry and tumor uptake of the \[131I\]/\[18F\]/\[68Ga\]ZT-111 in patients with PSMA positive metastatic prostate cancer.

Conditions

• Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer

Interventions

Type	Name	Description
RADIATION	[131I]/[18F]/[68Ga]ZT-111	\[131I\]/\[18F\]/\[68Ga\]ZT-111, single dose

Timeline

• Start date: 2023-12-27
• Primary completion: 2024-04-30
• Completion: 2024-06-30
• First posted: 2024-01-11
• Last updated: 2024-01-25

Locations

1 site across 1 country: China